Filter posts

Meet the Regulators: FDA’s Top Officials Join BIO “Town Hall”

Top U.S. Food and Drug Administration officials outlined the agency’s modernization efforts and proposed reorganization, …

Robin Roberts Shares the Journey

When Good Morning America co-anchor Robin Roberts was diagnosed with cancer in 2007, she took …

At #BIO2018, A Look at the State of Innovation

Innovation is at the forefront of the biotechnology industry, and at the 2018 BIO International Convention, …

NORD and the Orphan Drug Act Celebrate 35 Years Driving Rare Disease Advocacy, Research, and Innovat...

The National Organization for Rare Disorders (NORD) has been instrumental in influencing public policy, regulatory …

Countdown to #BIO2018 – One day to go!

First BIO President Carl Feldbaum Remembers Early, Existential Struggle Carl Feldbaum was a law student of …

Newborn Screening – How to Fill the Gap to End Diagnostic Odysseys

Many of the over 7000 rare diseases identified so far are not obvious at birth …

On the President’s Drug Cost Plan, Three Important Concerns

Part 3. Restricting access under Medicaid Is not the answer This week, BIO launched a …

On the President’s Drug Cost Plan, Three Important Concerns

Part 2. Upending Access in Medicare Part B program This week, BIO launched a three-part …

Lupus Patients Find Hope In the Face of Hardship

One and a half million and counting. That’s how many people suffer from lupus in …

On the President’s Drug Cost Plan, Three Important Concerns

Part 1. Restricting access under Medicare Part D  The Trump administration is out with its …